Recommendations from SCAI experts support the safety of PCI without on-site surgery

Published Date: 02 Mar 2023

Recommendations from SCAI experts support the safety of PCI without on-site surgery

Read Full News

Latest News

Planning Lung Cancer Screening, Surgery Between Clinicians and Patients Kevin Kunzmann

David Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Episode 3: Cracking the Code: Insulin Resistance in HS

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Aesthetician Charged With Injecting Customers With Counterfeit Botox

Some clients faced life-threatening injuries after receiving injections, said federal authorities

Todays Updates

CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis Marco Meglio

New phase 3 FREXCITE trial tests frexalimab CD40L inhibitor in nrSPMS, comparing on-body subcutaneous vs IV dosing

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers Marco Meglio

Findings from a phase 1 study indicated that Lucid-21-302 was generally well tolerated and exhibited dose-proportional exposure, warranting additional study in a phase 2 trial for multiple sclerosis.

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Todays Updates

CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis Marco Meglio

New phase 3 FREXCITE trial tests frexalimab CD40L inhibitor in nrSPMS, comparing on-body subcutaneous vs IV dosing

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers Marco Meglio

Findings from a phase 1 study indicated that Lucid-21-302 was generally well tolerated and exhibited dose-proportional exposure, warranting additional study in a phase 2 trial for multiple sclerosis.

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Latest News

David Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Some clients faced life-threatening injuries after receiving injections, said federal authorities

News All Time

Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study

Conducting pre-op and post-op visits via telemedicine saved patients thousands of driving miles

New Guideline Revises Cautions Around Dental Work in Joint Replacement Patients

Surgeons' groups acknowledge that prophylactic antibiotics may not cut infection risk

How 'General Hospital' Missed a Chance to Promote Living Organ Donation

A recent storyline offered a negative spin

Half-Truths, Big Risks: The Dangers of an Incomplete Medical History

Creating an environment that fosters open communication is essential

Anthem Blue Cross Blue Shield Reverses Decision to Put a Time Limit on Anesthesia

Change comes after widespread outcry

Inside the OR: Cervical Artificial Disc Replacement

Watch orthopedic spinal surgeon Antonio Webb, MD, perform this complex procedure

Trump's FDA Pick Is MedPage Today's Former Top Editor

Marty Makary has made a name for himself challenging the medical establishment

How Impactful is EMPACT-MI on Heart Failure: EMPACT-MI Trial

The trial evaluated the efficacy of empagliflozin to reduce cardiovascular risk in patients after acute myocardial infarction.

Nationwide IV Fluid Shortage Could Change How Hospitals Manage Patient Hydration

Crisis expected to last a long time, according to one expert

One-day Decompression at Allegheny Health Network

One-day Decompression at Allegheny Health Network

Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults

Targeted preventive strategies needed, especially for younger women, researchers say

Health Worker Gets 2 Years for Accessing Ruth Bader Ginsburg's Medical Records

Transplant coordinator was convicted earlier this year

The Robot Will See You Now

Robotics may not be the answer for primary care right now, but "smart systems" sure could help

Resistance Training Falls Short in Severe Hip Arthritis

Trial finds conservative approach inferior to joint replacement

People Opting Out of Organ Donation After Donor Mistakenly Declared Dead

The alleged incident even affected donations in France

I'm a Black Trauma Surgeon. Ending Gun Violence Demands Fighting for Racial Justice.

An excerpt from Williams' book, The Bodies Keep Coming

Recommended News For You

Early palliative care billing up from 2010 to 2019 for advanced cancer

Skinny melanoma incidence is associated with vitamin D deficiency.

Scientists identify dual protein targets to weaken pancreatic cancer defenses

AI could help improve early detection of interval breast cancers

Review looks at potential treatment targets in the tumor microenvironment.

Adult overdose deaths on the rise

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

Recommended Articles For You

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment 

A Closer Look at the Effects of Sickle Cell on Eyesight 

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Medical Journal March 28, 2023

2.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

3.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

4.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

5.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

1.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

2.

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025

3.

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma 

4.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

5.

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Navigating the Complexities of Ph Negative ALL - Part XIV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot